Transactions
Affichage de - 675 éléments sur 939
-
US$17m
Galena Biopharma
Sole Bookrunner (Follow-on Offering)
-
US$10m
Aldeyra
Joint Bookrunner (Follow-on)
-
US$125m
Synergy Pharmaceuticals Inc.
Joint Bookrunner (Follow-on)
-
A$45m
AirXpanders Inc
Lead Manager and Bookrunner (Placing)
-
US$110m
Xencor, Inc.
Co-Manager (Follow-on)
-
US$17m
Palatin Technologies, Inc.
Sole Bookrunning Manager (Placing)
-
US$201m
BioQ Pharma
Co-Manager (Follow-on)
-
US$200m
Nant Health
Co-Manager (Convertible Notes)
-
US$36m
TiGenix
Lead Manager (IPO)
-
US$75m
Obalon Therapeutics
Joint Bookrunner (IPO)
-
US$123m
iRhthym Technologies
Co-Manager (IPO)
-
US$172m
Advanced Accelerator Applications
Co-Manager (Follow-on)
-
N/a
Pure Communications
Financial Advisor to Pure Communications on its sale to W2O Group
-
US$201m
Sage Therapeutics
Co-Manager (Follow-on)
-
US$75m
Aquinox Pharmaceuticals, Inc.
Joint Bookrunner (Follow-on)
